183 related articles for article (PubMed ID: 2191038)
1. IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta.
Cooper KD; Hammerberg C; Baadsgaard O; Elder JT; Chan LS; Sauder DN; Voorhees JJ; Fisher G
J Immunol; 1990 Jun; 144(12):4593-603. PubMed ID: 2191038
[TBL] [Abstract][Full Text] [Related]
2. IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin.
Bonifati C; Carducci M; Mussi A; D'auria L; Ameglio F
J Biol Regul Homeost Agents; 1997; 11(4):133-6. PubMed ID: 9582612
[TBL] [Abstract][Full Text] [Related]
3. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes.
Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD
J Clin Invest; 1995 Jan; 95(1):317-27. PubMed ID: 7529261
[TBL] [Abstract][Full Text] [Related]
4. Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin.
Johansen C; Kragballe K; Rasmussen M; Dam TN; Iversen L
Br J Dermatol; 2004 Sep; 151(3):600-7. PubMed ID: 15377346
[TBL] [Abstract][Full Text] [Related]
5. Lesional psoriatic T cells contain the capacity to induce a T cell activation molecule CDw60 on normal keratinocytes.
Skov L; Chan LS; Fox DA; Larsen JK; Voorhees JJ; Cooper KD; Baadsgaard O
Am J Pathol; 1997 Feb; 150(2):675-83. PubMed ID: 9033280
[TBL] [Abstract][Full Text] [Related]
6. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.
Debets R; Hegmans JP; Croughs P; Troost RJ; Prins JB; Benner R; Prens EP
J Immunol; 1997 Mar; 158(6):2955-63. PubMed ID: 9058835
[TBL] [Abstract][Full Text] [Related]
7. Enhanced production of biologically active interleukin-1 alpha and interleukin-1 beta by psoriatic epidermal cells ex vivo: evidence of increased cytosolic interleukin-1 beta levels and facilitated interleukin-1 release.
Debets R; Hegmans JP; Troost RJ; Benner R; Prens EP
Eur J Immunol; 1995 Jun; 25(6):1624-30. PubMed ID: 7614991
[TBL] [Abstract][Full Text] [Related]
8. The helix-loop-helix transcription factor Id1 is highly expressed in psoriatic involved skin.
Björntorp E; Parsa R; Thornemo M; Wennberg AM; Lindahl A
Acta Derm Venereol; 2003; 83(6):403-9. PubMed ID: 14690332
[TBL] [Abstract][Full Text] [Related]
9. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro.
Schulz BS; Michel G; Wagner S; Süss R; Beetz A; Peter RU; Kemény L; Ruzicka T
J Immunol; 1993 Oct; 151(8):4399-406. PubMed ID: 7691948
[TBL] [Abstract][Full Text] [Related]
11. Demonstration and functional analysis of IL-10 receptors in human epidermal cells: decreased expression in psoriatic skin, down-modulation by IL-8, and up-regulation by an antipsoriatic glucocorticosteroid in normal cultured keratinocytes.
Michel G; Mirmohammadsadegh A; Olasz E; Jarzebska-Deussen B; Müschen A; Kemény L; Abts HF; Ruzicka T
J Immunol; 1997 Dec; 159(12):6291-7. PubMed ID: 9550434
[TBL] [Abstract][Full Text] [Related]
12. Elevated interleukin-18 protein expression in early active and progressive plaque-type psoriatic lesions.
Companjen A; van der Wel L; van der Fits L; Laman J; Prens E
Eur Cytokine Netw; 2004; 15(3):210-6. PubMed ID: 15542445
[TBL] [Abstract][Full Text] [Related]
13. Expression of interleukin-1 beta in a human keratinocyte cell line.
McKenzie RC; Arsenault TV; Sauder DN; Harley CB
Lymphokine Res; 1990; 9(3):391-403. PubMed ID: 2398743
[TBL] [Abstract][Full Text] [Related]
14. Comano's (Trentino) thermal water interferes with tumour necrosis factor-alpha expression and interleukin-8 production and secretion by cultured human psoriatic keratinocytes: yet other mechanisms of its anti-psoriatic action.
Dal Pra I; Chiarini A; Pacchiana R; Zumiani G; Zanoni M; Armato U
Int J Mol Med; 2007 Mar; 19(3):373-9. PubMed ID: 17273783
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin.
Johansen C; Usher PA; Kjellerup RB; Lundsgaard D; Iversen L; Kragballe K
Br J Dermatol; 2009 Feb; 160(2):319-24. PubMed ID: 19016708
[TBL] [Abstract][Full Text] [Related]
16. Biologically active, alternatively processed interleukin-1 beta in psoriatic scales.
Lundqvist EN; Egelrud T
Eur J Immunol; 1997 Sep; 27(9):2165-71. PubMed ID: 9341755
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1: a key inflammatory mediator in psoriasis?
Mee JB; Cork MJ; di Giovine FS; Duff GW; Groves RW
Cytokine; 2006 Jan; 33(2):72-8. PubMed ID: 16460958
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 in human skin: dysregulation in psoriasis.
Cooper KD; Hammerberg C; Baadsgaard O; Elder JT; Chan LS; Taylor RS; Voorhees JJ; Fisher G
J Invest Dermatol; 1990 Nov; 95(5 Suppl):24S-26S. PubMed ID: 16788624
[TBL] [Abstract][Full Text] [Related]
19. Quantification of chemotactic peptides (C5a anaphylatoxin and IL-8) in psoriatic lesional skin.
Takematsu H; Tagami H
Arch Dermatol; 1993 Jan; 129(1):74-80. PubMed ID: 8420495
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of a human endogenous retrovirus E transmembrane envelope glycoprotein in normal, psoriatic and atopic dermatitis human skin.
Bessis D; Molès JP; Basset-Séguin N; Tesniere A; Arpin C; Guilhou JJ
Br J Dermatol; 2004 Oct; 151(4):737-45. PubMed ID: 15491412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
